Wooyoung Hur
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 6
- Protein Kinase Regulation and GTPase Signaling 5
- Genomics, phytochemicals, and oxidative stress 3
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 3
- Genetics top 5%
- Organic Chemistry top 5%
- Quinazolinone synthesis and applications 3
- Toxicology top 5%
-
- HER2/EGFR in Cancer Research 5
- Cancer-related Molecular Pathways 3
-
- Eosinophilic Disorders and Syndromes 3
- Co-authors
- Nathanael S. GrayTaebo SimSheng DingEric C. PetersPeter G. SchultzDavid M. SabatiniJinhua WangSeong A. Kang
- Cited by
- Molecular BiologyHematologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)Journal of Medicinal Chemistry (5 papers)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Wooyoung Hur
34 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.3k
- Hematology 181
- Genetics 161
- Organic Chemistry 402
- Toxicology 41
Countries citing papers authored by Wooyoung Hur
This map shows the geographic impact of Wooyoung Hur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wooyoung Hur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wooyoung Hur more than expected).
Fields of papers citing papers by Wooyoung Hur
This network shows the impact of papers produced by Wooyoung Hur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wooyoung Hur. The network helps show where Wooyoung Hur may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wooyoung Hur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2018 | 8 | |
| 9 | 2017 | 50 | |
| 10 | 2016 | 18 | |
| 11 | 2012 | 25 | |
| 12 | 2011 | 10 | |
| 13 | Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer | 2010 | 11 |
| 14 | 2010 | 66 | |
| 15 | 2010 | 184 | |
| 16 | 2010 | 111 | |
| 17 | 2008 | 32 | |
| 18 | 2006 | 290 | |
| 19 | 2004 | 117 | |
| 20 | 2003 | 306 |
About Wooyoung Hur
Wooyoung Hur is a scholar working on Toxicology, Molecular Biology and Hematology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), HER2/EGFR in Cancer Research (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Cancer-related Molecular Pathways (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Quinazolinone synthesis and applications (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Hematology (181 citations) and Genetics (161 citations). Wooyoung Hur has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Nathanael S. Gray, Taebo Sim, Sheng Ding, Eric C. Peters, Peter G. Schultz, David M. Sabatini, Jinhua Wang, Seong A. Kang, Qingsong Liu and Carson C. Thoreen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.